Clinical Trials Browser

Phase 3 × Terminated × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all

NCT01875653 2019-05-10

Autologous Dendritic Cell-Tumor Cell Immunotherapy for Metastatic Melanoma

Phase 3 Terminated

Melanoma